Hantech Bio-Technology Co., Ltd. (1294) Stock Price & Analysis

1294 Stock Chart & Stats

NT$44.30-NT$2.10(-4.53%)

At close: Nov 06 12:30 AM EST

Day’s Range: TWD 43.75 - TWD 45.35
52-Week Range: TWD 43.75 - TWD 79.42
Previous Close: TWD 46.40
Volume: N/A
Average Volume (3M): 16.71K
Market Cap: TWD 1.61B
Enterprise Value: TWD 2.61B
Total Cash (Recent Filing): TWD 374.05M
Total Debt (Recent Filing): TWD 107.40M
Price to Earnings (P/E): 10.5
Beta: 0.10
Next Earnings: N/A
EPS Estimate: N/A
Last Dividend Ex-Date: Jul 03, 2026
Dividend Yield: 6.77%

Bulls Say, Bears Say

Bulls Say

Sustained Revenue Expansion

Revenue growth through 2025 indicates sustained demand and expanding business scale rather than reliance on a single reporting period. Continued top-line expansion can support operating leverage, strengthen market presence, and provide a durable base for reinvestment over the next several quarters.

Healthy Profitability

Strong net and EBIT margins show that the company currently converts revenue into substantial operating and bottom-line profit. This profitability provides internal funding capacity and resilience, while giving management room to absorb moderate cost pressure without immediately impairing earnings.

Conservative Balance Sheet

Very low leverage reduces financial risk and preserves flexibility for investment, dividends, or managing weaker conditions. The combination of a conservative capital structure and attractive ROE suggests the company is generating meaningful returns without relying heavily on debt financing.

Bears Say

Inconsistent Cash Conversion

Cash generation has not consistently matched reported profitability, with operating cash flow below net income and a history of negative free cash flow. The 2025 decline adds pressure, potentially limiting internally funded growth and making cash conversion an ongoing quality concern.

Margin Compression

The broad decline in gross, EBIT, and net margins suggests that recent revenue growth is producing less profit per dollar than in earlier periods. If sustained, higher costs, pricing pressure, or mix changes could reduce operating leverage and weaken earnings growth over the medium term.

Cooling Capital Efficiency

Although 2025 ROE remains attractive, its decline from the unusually high 2023 level indicates that profit generation has become less efficient on the larger equity base. Further normalization could constrain returns from retained capital and reduce the pace of shareholder value creation.

1294 FAQ

What was Hantech Bio-Technology Co., Ltd.’s price range in the past 12 months?

Hantech Bio-Technology Co., Ltd. lowest stock price was TWD 43.75 and its highest was TWD 79.42 in the past 12 months.

What is Hantech Bio-Technology Co., Ltd.’s market cap?

Hantech Bio-Technology Co., Ltd.’s market cap is TWD 1.61B.

When is Hantech Bio-Technology Co., Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Hantech Bio-Technology Co., Ltd.’s earnings last quarter?

Hantech Bio-Technology Co., Ltd. released its earnings results on Nov 12, 2026. The company reported TWD 0.609 earnings per share for the quarter.

Is Hantech Bio-Technology Co., Ltd. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Hantech Bio-Technology Co., Ltd. pay dividends?

Hantech Bio-Technology Co., Ltd. pays a ― dividend of TWD 3 which represents an annual dividend yield of 6.77%. See more information on Hantech Bio-Technology Co., Ltd. dividends here

What is Hantech Bio-Technology Co., Ltd.’s EPS estimate?

Hantech Bio-Technology Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hantech Bio-Technology Co., Ltd. have?

Hantech Bio-Technology Co., Ltd. has 36,625,874 shares outstanding.

What happened to Hantech Bio-Technology Co., Ltd.’s price movement after its last earnings report?

Hantech Bio-Technology Co., Ltd. reported an EPS of TWD 0.609 in its last earnings report. Following the earnings report the stock price went down -1.523%.

Which hedge fund is a major shareholder of Hantech Bio-Technology Co., Ltd.?

Currently, no hedge funds are holding shares in TW:1294

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description